Entering the Qatari market with an exclusive distribution agreement for its key products, T2 Biosystems is poised to increase its sales and expand its global footprint. This strategic move is likely to be viewed positively by investors, as it opens up new revenue streams and demonstrates the company's growth potential in international markets. The direct impact on TTOO's stock will depend on the market's perception of this expansion's potential to drive revenue growth.